Breaking News Instant updates and real-time market news.

APOG

Apogee Enterprises

$40.67

-0.63 (-1.53%)

06:54
10/02/18
10/02
06:54
10/02/18
06:54

Apogee Enterprises initiated with a Neutral at Goldman Sachs

Goldman Sachs analyst Doug Clark started Apogee Enterprises with a Neutral rating and $43 price target. The analyst rolled out coverage on the Building Products sector with Neutral rating.

APOG Apogee Enterprises
$40.67

-0.63 (-1.53%)

04/13/18
CHLM
04/13/18
NO CHANGE
Target $55
CHLM
Buy
Apogee Enterprises price target lowered to $55 from $60 at Craig-Hallum
Craig-Hallum analyst Eric Stine lowered his price target on Apogee Enterprises to $55 from $60 following the company's "mixed" Q4 results. In a research note to investors, Stine said he believes the company's outlook is "intact" despite lower guidance for fiscal 2019, due primarily to EFCO, which he said is likely to turn out to be a "good" acquisition strategically and that the new management put in place earlier this year should help improve performance going forward. However, Stine contended that these factors will have little impact on the "problem projects" already in its backlog. Stine, who has a Buy rating on Apogee shares, said investors "should not let EFCO distract" from positive trends across most of Apogee's businesses.
06/29/18
DADA
06/29/18
DOWNGRADE
DADA
Neutral
Apogee Enterprises downgraded to Neutral from Buy at DA Davidson
06/29/18
DADA
06/29/18
DOWNGRADE
Target $52
DADA
Neutral
Apogee Enterprises downgraded to Neutral at DA Davidson on valuation
As reported earlier, DA Davidson analyst Brent Thielman downgraded Apogee Enterprises to Neutral from Buy but raised his price target to $52 from $47 after the company's Q1 earnings beat and raised FY19 EPS outlook. Thielman points to diminished EFCO execution risk and improving prospects for the company's glass business, stating that segment margins have started to recover as problem contracts are being addressed. The analyst also notes positive backlog and order trend revealed in the latest earnings, but adds that the subsequent 13% rally in the stock price takes valuation to levels where risk-reward is more balanced.
09/19/18
DADA
09/19/18
NO CHANGE
Target $48
DADA
Neutral
Apogee Enterprises price target lowered to $48 from $52 at DA Davidson
DA Davidson analyst Brent Thielman lowered his price target on Apogee Enterprises to $48 and kept his Neutral rating after its Q2 earnings miss and reduced FY19 EPS and revenue expectations. The analyst points to the near-term headwinds related mainly to the company's Glass segment and production inefficiencies, along with continued integration challenges of an acquisition in the Framing Systems. Thielman contends that Apogee is "building a better overall business with more diversity in end markets and projects", but also expects any stock price appreciation to be dependent on better execution and improved margins in the second half of 2018.

TODAY'S FREE FLY STORIES

ACB

Aurora Cannabis

$7.61

(0.00%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Aurora Cannabis falls -12.5% »

Aurora Cannabis is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATI

Allegheny Technologies

$22.90

-3.92 (-14.62%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Allegheny Technologies falls -13.7% »

Allegheny Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

EDU

New Oriental Education

$54.97

-7.78 (-12.40%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
New Oriental Education falls -13.5% »

New Oriental Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

LABD

Daily S&P Biotech Bear 3x Shares

$37.44

2.23 (6.33%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Daily S&P Biotech Bear 3x Shares rises 6.8% »

Daily S&P Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$6.46

0.49 (8.21%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Britannia Bulk rises 7.9% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$60.57

7.23 (13.55%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 13.9% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
10/23/18
10/23
09:45
10/23/18
09:45
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

TSLA

Tesla

$263.12

2.09 (0.80%)

09:45
10/23/18
10/23
09:45
10/23/18
09:45
Hot Stocks
Citron reverses opinion on Tesla, goes long shares into earnings »

Citron Research, best…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

09:45
10/23/18
10/23
09:45
10/23/18
09:45
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

09:45
10/23/18
10/23
09:45
10/23/18
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

October Richmond Fed…

VFC

VF Corp.

$77.62

(0.00%)

09:43
10/23/18
10/23
09:43
10/23/18
09:43
Recommendations
VF Corp. analyst commentary  »

VF Corp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$95.61

(0.00%)

09:42
10/23/18
10/23
09:42
10/23/18
09:42
Technical Analysis
Technical Take: Market Vectors Semiconductor at new 52-week low, major top »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$204.52

(0.00%)

09:40
10/23/18
10/23
09:40
10/23/18
09:40
Options
Unusually active option classes on open October 23rd »

Unusual total active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HON

Honeywell

$152.63

-0.86 (-0.56%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
Honeywell rating change  »

Honeywell upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTS

QTS Realty Trust

$40.40

-0.59 (-1.44%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Upgrade
QTS Realty Trust rating change  »

QTS Realty Trust upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

EXPI

eXp World Holdings

$12.50

0.35 (2.88%)

09:39
10/23/18
10/23
09:39
10/23/18
09:39
Hot Stocks
eXp Realty to acquire ShowMeNow, terms not disclosed »

eXp Realty, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TSLA

Tesla

$261.03

0.97 (0.37%)

09:38
10/23/18
10/23
09:38
10/23/18
09:38
Periodicals
Breaking Periodicals news story on Tesla »

Citron says long Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

KOF

Coca-Cola Femsa

$59.41

-1.75 (-2.86%)

09:36
10/23/18
10/23
09:36
10/23/18
09:36
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.93

0.34 (0.71%)

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Oracle initiated  »

Oracle initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Conference/Events
JPMorgan European & EMEA analysts to hold analyst/industry conference call »

European Utilities…

ABBV

AbbVie

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
AbbVie initiated  »

AbbVie initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

SNY

Sanofi

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Sanofi initiated  »

Sanofi reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

RHHBY

Roche

09:35
10/23/18
10/23
09:35
10/23/18
09:35
Initiation
Roche initiated  »

Roche reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 24

    Dec

09:35
10/23/18
10/23
09:35
10/23/18
09:35
General news
Treasury 2-year auction outlook: the $38 B 2-year sale »

Treasury 2-year auction…

PFE

Pfizer

$44.37

-0.13 (-0.29%)

09:34
10/23/18
10/23
09:34
10/23/18
09:34
Initiation
Pfizer initiated  »

Pfizer reinitiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.